Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
REVENUE	$ 1,417,725	$ 398,200
Cost of Revenue	725,271	338,335
Gross Profit	692,454	59,865
EXPENSES
General and administrative expenses [Note 5, 7, 9 and 11]	10,259,903	7,342,739
Research and development expenses	1,363,235	1,309,191
TOTAL OPERATING EXPENSES	11,623,138	8,651,930
Other income [Note 3]	(16,939)
Accretion expense [Note 5]	92,416
Change in fair value of derivative liabilities [Note 6]	60,781
NET LOSS BEFORE INCOME TAXES	(11,066,942)	(8,592,065)
Income taxes [Note 8]
NET LOSS BEFORE DIVIDENDS	(11,066,942)	(8,592,065)
Less: Preferred Stock Dividends [Note 7]	257,928
NET LOSS ATTRIBUTED TO COMMON STOCKHOLDERS	(11,324,869)	(8,592,065)
Translation adjustment	(102,344)	(111,834)
COMPREHENSIVE LOSS	$ (11,427,213)	$ (8,703,899)
LOSS PER SHARE, BASIC AND DILUTED	$ (0.315)	$ (0.257)
WEIGHTED AVERAGE NUMBER OF COMMON AND EXCHANGEABLE SHARES OUTSTANDING	35,956,180	33,376,068